 The purpose of this study is to perform first-in-human PET imaging studies of two new cardiac sympathetic nerve imaging agents, 4-18Ffluoro-meta-hydroxyphenethylguanidine 18F4F-MHPG and 3-18Ffluoro-para-hydroxyphenethylguanidine 18F3F-PHPG. 